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Molecular gelators are currently receiving a great deal of attention. These are small molecules 
which, under the appropriate conditions, assemble in solution to, in the majority of cases, give long 
fibrillar structures which entangle to form a three-dimensional network. This immobilises the 
solvent, resulting in a gel. Such gelators have potential application in a number of important areas 
from drug delivery to tissue engineering. Recently, the use of peptide-conjugates has become 10 
prevalent with oligopeptides (from as short as two amino acids in length) conjugated to a polymer, 
alkyl chain or aromatic group such as naphthalene or fluorenylmethoxycarbonyl (Fmoc) being 
shown to be effective molecular gelators. The field of gelation is extremely large; here we will 
focus our attention on the use of these peptide-conjugates as molecular hydrogelators. 
1. Introduction 15 
1.1. Hydrogels 
Hydrogels comprise a water phase immobilised by a 
scaffold.1-3 This scaffold gives structure to the aqueous phase 
and results in a gel. Hydrogels are of wide interest due to the 
biocompatibility of the systems with applications in areas 20 
such as drug delivery (where either the scaffold or aqueous 
pool can be used as a reservoir for other components4-6), 
tissue engineering (where hydrogels are used as 3D scaffolds 
to support the growth of cultured cells, mimicking the 
extracellular matrix),7-22 biomineralisation23 and contact 25 
lenses.24, 25 The scaffold can be formed in a number of ways. 
Often, polymeric scaffolds are used. These can be naturally 
occurring polymers such as polysaccharides (including pectin 
and alginate26, 27) or synthetic polymers such as cross-linked 
poly(ethylene oxide) (PEO) or 30 
poly(hydroxyethylmethacrylate).28 In these latter cases, the 
polymers, which are water soluble, are induced to form a non-
soluble matrix by cross-linking. This cross-linking is usually 
carried out by the incorporation of a nominal quantity of 
bifunctional monomer with UV radiation or redox initiated 35 
chemistry. Depending on the application, this method can 
have drawbacks. For example, if cells are to be encapsulated 
in the gels, the radicals present during the polymerisation can 
cause damage to cells.29 Additionally, this cross-linking step 
often means that in those cases where encapsulation is 40 
required, the drug or other encapsulant molecule has to be 
added post-cross-linking to avoid reaction with the monomers 
or cross-linker. An alternative strategy is to make use of low 
molecular weight compounds that assemble in solution in such 
a way as to form a network of fibres, Figure 1. This strategy is 45 
currently generating interest, particularly when using peptide-









Figure 1. Assembly of peptide-conjugates in water via non-
covalent forces (including hydrogen-bonding, electrostatics, 
π-stacking and hydrophobicity) leads to the formation of 
fibrous structures. In this example, anti-parallel β-sheets are 
formed between the peptide-conjugates. Entanglement of 60 
these fibres leads to a three-dimensional network which 
immobilises the water, resulting in a hydrogel as demonstrated 
by the lack of flow on vial inversion.  
 
1.2. Peptide-based self-assembled systems 65 
A large number of molecules are known to be capable of 
forming one-dimensional fibres which then entangle to form 
the matrix of the gel. The design rules for what will or will 
not form a network remain unclear,30 with often very similar 
compounds having very different behaviour. Nonetheless, it is 70 
known that the fibres are formed via assembly through non-
covalent forces such as hydrogen-bonding, π-stacking, 
electrostatics and hydrophobic forces and are formed when the 
precise balance of hydrophilicity and hydrophobicity is 
present. Individually, these interactions are quite weak. 75 
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Collectively, however, they can give rise to extremely stable 
structures.31 Within these forces, there are different 
requirements. Hydrogen-bonding requires precisely positioned 
donors and acceptors. In peptidic systems, depending on the 
sequence of amino acids, hydrogen-bonding can lead to the 5 
formation of ordered secondary structures including -helices, 
β-sheets and anti-parallel β-sheets. Efficient π-stacking 
requires the overlapping of aromatic rings being of the order 
of 3.4 Å apart. On the other hand, electrostatic interactions are 
not directional and are also more flexible in terms of the 10 
distance between the participating charges. Hydrophobic 
interactions are even less directionally constrained than 
electrostatic interactions. 
 Supramolecular hydrogels prepared using these forces have 
properties which are very different to those arising from 15 
cross-linked polymer hydrogels. Since the matrix is held 
together by non-covalent interaction, the gels tend to have 
rapid response to chemical or physical stimuli such as pH and 
temperature. In addition, on disassembly, the low molecular 
weight molecules would be expected to be cleared efficiently 20 
in vivo, leading to good biodegradability. The concentrations 
of gelator required are often far lower than for systems using 
conventional synthetic polymers. As such, there is a higher 
water content, meaning that such gels are potentially more 
biocompatible.32 Peptides11, 17, 19, 33-49 and polymer-peptide 25 
conjugates50-53 have emerged as promising gelators since their 
assembly in water results from such non-covalent forces. 
Here, we will discuss the use of peptide conjugates as low 
molecular weight hydrogelators. Specifically, we will discuss 
the formation of hydrogels using peptides conjugated to a 30 
large aromatic group such as naphthalene or Fmoc, peptide 
amphiphiles (PAs, where a hydrophobic alkyl chain is 
connected to a hydrophilic peptide) and polymer-peptide 
conjugates where the peptide block is short or sequence 
specific. Block copolypeptides are beyond the scope of this 35 
review and the reader is directed to the work of Deming.54 
Protein-based55-57 and oligopeptide-based hydrogels are also 
well-known11, 12, 39, 40, 58-62 but will not be discussed here. 
Throughout this review, three letter abbreviations for amino 
acids will be used. 40 
2. Material Properties 
An important consideration when designing hydrogels is the 
target material and mechanical properties for the application in 
mind. Hydrogels, being primarily composed of water, tend to be 
weak materials. A number of biological materials are hydrogel-45 
based. For example, cornea is a proteoglycan gel, which contains 
approximately 20 % collagen fibres. This cartilage has a tensile 
strength of approximately 4 MPa.63 For many tissue engineering 
applications, matching the mechanical properties of the gel with 
the tissue involved is critical for effective function.10, 64, 65 Gels 50 
are also used in drug delivery, where porosity and mesh size are 
important considerations in addition to the mechanical properties, 
although these parameters can be closely related (for example, 
controlling the cross-link density can increase the strength whilst 
reducing the „porosity‟).66, 67 Here, triggered release is also an 55 
important consideration, thus a stimuli-responsive material is 
often required. For cell culturing, optimisation of both nutrient 
diffusion and mechanical properties is vital.68 In all of these 
cases, biocompatibility is of paramount importance. 
 60 
Figure 2. Vial-inversion demonstrating a lack of flow and hence 
the formation of a gel. Taken from Adams et al.71 Reproduced by 
permission of The Royal Society of Chemistry 
Over the years, a number of methods for measuring the material 
properties of hydrogels have been developed.69 Unlike hydrogels 65 
prepared using polymeric scaffolds, gels prepared via the 
assembly of low molecular weight building blocks can have a 
very low concentration of scaffold. Consequently, these gels can 
be difficult to work with. For example, it is commonly impossible 
to clamp the gels; hence a number of methods for measuring the 70 
tensile strength are impossible. For the hydrogels discussed here, 
therefore, the number of methods used to measure the mechanical 
properties is limited. First, a significant number of reports make 
use of what has been described as “Table-top Rheology”, based 
on the concept that “a gel should not flow under the action of a 75 
mechanical stress imposed for an infinite period of time”.70 
Hence, simple inversion of a vial can be used to distinguish 
between a gel and a sol, with the gel showing no flow, Figure 2. 
Similarly, dense spherical particles can be suspended in physical 
gels that have appreciable yield stresses. A lack of sedimentation 80 
is indicative of a gel, whereas the particles will fall for a viscous 
liquid.70 Whilst useful in determining the phase space for 
gelation, these methods cannot be used to accurately measure the 
mechanical properties of the gel. Nonetheless, these methods are 
the most highly reported in the literature for the demonstration of 85 
the formation of a gel. As a result, direct comparison between 
different systems is often extremely difficult. Additionally, since 
these methods do not give any information regarding the 
mechanical properties of the gels, it is often impossible to 
determine which applications such gels may be suitable for. 90 
 Rheological data is available for a number of materials. 
Rheometry (or rheology) is the science of deformation and 
flow.72 Here, the viscoelastic behaviour of the materials is 
measured under the application of a stress. The two 
rheological criteria required for a gel are the independence of 95 
the dynamic elastic (or storage) modulus (G ′) on the 
oscillatory frequency, and that G′ exceeds the loss modulus 
(G″) by approximately one order of magnitude.73 G′ is an 
indicator of the elastic behaviour and measures the ability to 
store deformation energy that can be recovered after removing 100 
the load cycle. A number of different measurements can be 
carried out, including frequency sweeps and strain sweeps, 
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where the behaviour of the gel at different frequencies or 
strains is measured. Typically, for a frequency sweep, the 
hydrogel is sandwiched between two parallel plates. The top 
plate is then oscillated backwards and forwards at different 
frequencies whilst the values of G′ and G″ are measured. 5 
These measurements are routinely carried out, but there are 
differences between the geometries used to make the 
measurements (e.g. parallel plates or a vane) and also the way 
in which the measurements are executed (e.g. some gels are 
prepared in situ, whereas others are pre-prepared and loaded 10 
onto the rheometer). Typical rheological data are shown in 
Figure 3 for a PEO-peptide hydrogelator at different 
concentrations. As commonly observed for gels formed via 
the assembly of low molecular weight gelators, Figure 3a 
shows that G′ increases slightly with frequency. Semiflexible 15 
network elasticity theories have been used to define the 
characteristic network and chain dimensions for such 
systems.74-76 In the case of the PEO-peptide shown in Figure 
3, the plateau modulus of the hydrogel scales with the peptide 
concentration raised to the power 2.4 (i.e. G′ ∝ c2.4) implying 20 
that the increase in G′ and G′′ at higher PEO-peptide 
concentrations can be ascribed to the increasing degree of 
entanglement of the nanotubes giving rise to the gel. 
However, it should be noted that such a concentration 
dependence is not always observed. Recent results 25 
demonstrate that the modulus for a peptide amphiphile 
hydrogel scales with an exponent of 1.51 or 2.14 depending 
on the method of self-assembly.77 It is likely therefore as more 
data becomes available that very different types of network 
are being formed in these systems between which “Table-top 30 
rheology” is unable to distinguish. 
 Some gelators are only prepared on a very small scale, 
sometimes below the amounts required for rheometry. Here, 
an alternative is to use microrheology, where the thermal 
motion of particles embedded in a gel is tracked.78-80 35 
Microrheology is sensitive to the low viscoelastic properties 
at low moduli. Small sample volumes (<50 µL) are needed. 
No external force is applied so there is a minimal risk of 
disturbing fragile microstructures. However, correlation with 
rheometric data is uncommon and it is often unclear as to the 40 
effect of the embedded particles on the microstructure of the 
gels. Nevertheless, this can be a useful comparative tool when 
only small quantities are available. 
Information regarding the mesh size of the gels can be 
determined from measurements on the diffusion of probe 45 
molecules within the gel. Measurement of the diffusion rate 
for molecules of different sizes can be used to probe the 
network,81, 82 although care must be taken as specific 
interactions between the probe molecules and the network can 
also affect the diffusion rate.4 Recently, proton diffusion has 50 
been used to probe the size of the water domains within a self-
assembled peptide hydrogel, revealing quantitative 
information on mesh size.83 
3. Synthetic Approaches 
There are a number of different synthetic approaches for 55 
producing peptide conjugates, with each process integrating 
controlled techniques to produce well-defined bio-inspired 
molecules. The choice of approach is driven by the type of 
self-assembly mechanism required by the end-user. This 
review will discuss synthetic approaches that have been used 60 
to create the specific gelators discussed above. For more 
comprehensive reviews and highlights concerning the 
synthetic techniques employed to fabricate peptide hydrids of 
varying types, the reader is directed to work by Kros,84  
Haddleton85 and Klok.86, 87 Artificial peptide construction is 65 
carried out in one of four ways; expression (for generally 
more complex proteins),88, 89 N-carboxyanhydride (NCA) 
polymerisation (for blocks of homopolypeptides),54 solid-
phase amino acid coupling or solution-phase coupling (both 
for sequence specific chains). This section briefly compares 70 
and contrasts the two amino acid coupling procedures only, as 
protein expression and NCA polymerisation approaches have 
not been employed to fabricate the self-assembling molecules 
discussed in this review (although protein expression has been 
used to prepare protein-based gelators55-57 and NCA 75 
polymerisation is used to prepare block copolypeptide 
gelators54). Following peptide construction, we move on to 
discuss the methods of polymer incorporation. Incorporation 
strategies fall into one of two classes; convergent and 
divergent syntheses. Convergent methodologies require a 80 
conjugation step, where both building blocks are synthesised 
initially and then coupling together via ligation. Divergent 
approaches on the other hand require either the modification 
of the peptide or polymer block (to subsequently allow 
“growth” of the other component from first moiety) or the 85 
conversion of the peptidic component into a macromonomer 
for subsequent copolymerisation. This latter approach, also 
known as “grafting through”, is often not referred to as a 
divergent approach as the peptide sequence has already been 
defined prior to incorporation along the polymer backbone.86 90 
Figure 3. Rheology data for mPEO7-PhePhePhePhe. a) 
Frequency sweep data for different concentrations of fresh 
solutions of mPEO7-PhePhePhePhe-OEt in water after dialysis; 
2.7 mg mL-1 (); 4.3 mg mL-1 (); 6.3 mg mL-1 (▲); 8.7 mg 
mL-1 (); 11.0 mg mL-1 () and 14.4 mg mL-1 (). b) Storage 95 
modulus (G′) against concentration, where the solid line 
represents a linear fit of the data. Reprinted with permission from 
Tzokova et al.51 Copyright 2009 American Chemical Society. 
3.1. Amino Acid Coupling 
Both solution-phase and solid-phase amino acid coupling 100 
techniques allow the construction of sequence specific 
peptides, unlike NCA polymerisation, which affords 
homopolypeptide blocks. Solution-phase is useful for short 
peptide blocks containing less than ten amino acid residues.90 
Appropriately protected amino acids are dissolved in an 105 
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organic solvent and reacted together at their respective N- and 
C-termini. Activation of the C-terminus is usually required 
and can be achieved by a number of means.91 Judicious choice 
of protecting groups means that either the N- or C-terminus 
can then be deprotected for further reaction. 5 
Solid-phase amino acid coupling (also known as solid-
phase peptide synthesis, SPPS) was first introduced by 
Merrifield92 in 1963 and is most efficient for producing short 
to medium peptides (up to 50 residues86). The C-terminus end 
of the peptide chain is anchored to a solid support resin, 10 
which leaves the N-terminus end free to react with the free C-
terminus of an N-terminus protected amino acid in solution (in 
excess). Following removal of the protecting group on the N-
terminus of the resin-based peptide, the next solution-based 
peptide can be introduced or, alternatively, the peptide 15 
sequence can be cleaved from the solid resin, which is filtered 
off to afford the final product in extremely high yield. Each 
step is quasi-quantitative, but cumulative steps result in lower 
final yields. Consequently, one should turn to protein 
expression to create sequence-specific peptide chains 20 
comprising greater than 50 amino acid residues. 
3.2. Divergent Peptide Incorporation 
There are three significant divergent approaches for creating 
peptide-amphiphiles or polymer-peptide conjugates; (i) 
peptide construction from a polymer (or hydrocarbon for PAs) 25 
substrate, (ii) polymerisation from a peptidic initiator and (iii) 
copolymerisation incorporating a peptide macromonomer. 
Peptide construction from a polymer substrate.  Amino acid 
coupling can be carried out on commercially available PEO-
loaded resins. These supports contain chain-end functionalised 30 
PEO and are used in the same manner as SPPS, with the 
exception that, following cleavage from the resin, the final 
product contains a PEO block.93, 94 Although this approach 
produces well-defined polymer-peptide conjugates with 
simple purification strategies, pre-loaded resins are only 35 
currently available with PEO anchored to the surface and the 
range of available molecular weights is limited. This is where 
we must turn to different approaches to afford hybrid peptide 
conjugates with a wider variety of molecular weight, chemical 
composition and molecular structure.95 40 
Stupp‟s group96-98 have synthesised branched PAs by 
coupling palmitic acid to the -amine on a lysine residue, 
which was anchored to the solid surface on a resin. The 
remainder of the amino acid sequence was then constructed 
using selective orthogonal protecting groups. Behanna et al.99 45 
also used SPPS to synthesise reverse PAs where the peptide 
construction was carried out after introduction of the 
hydrophobic component, using standard Fmoc coupling on a 
Rink resin-loaded fatty acid to yield PAs with free N-termini. 
Polymerisation from a peptidic initiator.  There are a vast 50 
number of examples in the literature where peptides (and 
indeed proteins) have been modified to carry an appropriate 
functional group to initiate (or conduct chain transfer in the 
case of RAFT) a controlled polymerisation. A wide variety of 
polymer-peptide constructs are available with this method. 55 
However the approach has not been widely employed to 
fabricate hydrogelators. This is somewhat surprising since the 
method has been shown to be extremely effective for 
producing well-defined polymer-peptide conjugates.100-104 For 
a comprehensive review on controlled polymerisation from 60 
peptidic initiators (up to late 2006), the reader is directed to 
work by Haddleton and co-workers.85 The only work known 
to us at this time which used this approach to produce 
polymer-peptide hydrogelators is that of Mei et al.105 The 
authors describe a conventional heterogeneous polymerisation 65 
strategy whereby the peptidic initiator was bound to a solid-
support. 2-Hydroxyethyl methacrylate was polymerised from 
a Wang resin support via ATRP and the conjugate was 
subsequently cleaved from the resin using trifluoroacetic acid. 
Copolymerisation incorporating a peptide macromonomer.  70 
Peptide macromonomers have been used to produce 
chemically crosslinked hydrogels by a number of groups, with 
selected examples of the work by Bencherif,106 Hu107 and 
Zimmermann.108 However, there is currently only one 
example in the literature where a peptide macromonomer was 75 
designed to form polymer-peptide constructs which self-
assembled to form hydrogels. Wu et al.109 reacted the N-
terminus of an amino acid sequence with a methacryloyl-
based carboxylic acid and subsequently copolymerised the 
peptide macromonomer with poly(N-(2-hydroxypropyl) 80 
methacrylamide). Although this approach is somewhat 
elegant, the reported yields of the peptide macromonomer 
synthesis were 5 – 15 %. Ayres et al.110 did indeed report the 
self-aggregation of an elastin-like polymer-peptide construct, 
however there was no discussion regarding hydrogelation of 85 
these materials. A very recent example of a polymer-peptide 
copolymer (synthesised from an oligolysine macromonomer), 
which was shown to form gels at specific concentrations 
during polymerisation has been highlighted. The authors of 
this work, however, wished to avoid the presence of gel and 90 
so employed conditions to ensure that the material remained 
in solution.111 
3.3. Convergent Peptide Incorporation 
The most common method for producing peptide conjugates is 
a convergent approach because the building block materials 95 
are often incompatible with one another. Convergent 
strategies involve the parallel syntheses of both polymer and 
peptide constructs followed by a coupling step, Figure 4. 
The coupling step employed relies on the success of chemical 
ligation; reactions derived from small molecule organic 100 
chemistry. Difficulties arise when employing such reactions 
with macromolecules, due to the significantly lower 
concentration of functional groups and the potential steric 
barriers at reaction sites.113 To improve yields, highly efficient 
coupling reactions are sought in combination with excess 105 
reagent equivalents. The most common coupling reactions 
used involve “click” reactions,114, 115 such as maleimide-thiol 
conjugation116, 117 and copper(I)-catalysed azide-alkyne 
cycloadditions.118, 119 For example, Yang et al.52, 120 used free 
radical polymerisation to polymerise statistical copolymers of 110 
poly(N-(2-hydroxypropyl)methacrylamide-co-N-(3-
aminopropyl) methacrylamide), as shown in Figure 4a. The 
primary amine groups were then reacted to afford a polymer 
backbone with pendant maleimide groups. These groups were 
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then clicked to thiol-terminated amino acid sequences. Final 
yields of 40 – 60 % were reported. Jing et al.53 also used this 
coupling reaction to afford polymer-peptide hydrogelators. 
However, this time, triblock copolymers were afforded with 
varying success (24 – 41 % yields) by reacting bismaleimide-5 
terminated PEO with a cysteine-terminated peptide (Figure 
4b). Tzokova et al.51 used azide-alkyne coupling to produce a 
low molecular weight hydrogelator where a short PEO chain 
was coupled to tetraphenylalanine (PEO7-PhePhePhePhe), 
Figure 4d. Monohydroxy PEO7 was converted to PEO7-N3 and 10 
subsequently reacted with an alkyne-modified PhePhePhePhe 
moiety (synthesised by solution phase amino acid coupling) 
with 73 % click efficiency. Pegylation, the coupling of PEO to 
peptides or proteins, is a well-studied field (due to the 
biocompatibility of PEO and its effect in prolonging the 15 
lifetime of biological compounds in the body) and is reviewed 
in detail elsewhere.121  
Figure 4. Selected convergent approaches for the synthesis of 
peptide conjugates; A) HPMA-peptide graft copolymers,52 B) 
peptide-PEO-peptide triblock copolymers,53 C) peptide 20 




For PA synthesis, alkylation is generally achieved by standard 
amidation following peptide construction. The hydrophobic 25 
aliphatic chain can be a fatty acid (typically palmitic acid), 
which reacts with the amine of the N-terminus of the peptidic 
molecule23, 99, 122-127 to produce conventional peptide 
amphiphiles or an alkylamine which reacts with the carboxylic 
acid at the C-terminus112 to yield “reverse” PAs (see Figure 4c 30 
and section 4.2). 
4. Peptide Conjugate Hydrogelators 
Here, we review the three main classes of peptide-conjugates 
that have been shown to be efficient hydrogelators.  
4.1. Peptides Conjugated to Aromatic Groups 35 
There has recently been considerable work carried out on the use 
of functionalised-dipeptides as hydrogelators. Dipeptides are 
clearly of interest from a commercial point of view, being 
significantly cheaper than longer oligopeptides. Certain 
unfunctionalised dipeptides have been shown to form hydrogels. 40 
For example, de Groot et al. showed that isovaline-
phenylalanine128 forms gels at 1.5 wt% at pH 5.8. Assembly 
occurred here by specific ionic interactions between N and C 
termini of the peptide. Interestingly, a slightly less hydrophobic 
dipeptide (valine-phenylalanine) failed to yield hydrogels. The 45 
assembly of an aqueous solution of ,β-dehydrophenylalanine 
into hydrogels has also been reported at a concentration as low as 
0.2 wt% in a buffer solution.129 Diphenylalanine has been shown 
to assemble into nanotubes or nanowires130-132 depending on the 
conditions of assembly. This implies that the assembly into fibres 50 
observed with ,β-dehydrophenylalanine leading to 
hydrogelation arises from the conformational differences 
compared to the L,L-dipeptide. These are rare examples, however. 
A number of other dipeptides have been shown to crystallise in 
aqueous solutions.133 55 
Figure 5. Structures of example N-functionalised dipeptide 
gelators. (a) Fmoc-L-Ala-L-Ala
134 (b) Pyrene-dipeptide135 (c) 
Naphthalene-dipeptide.136 
 60 
On the other hand, a large number of reports now demonstrate 
that dipeptides conjugated to a hydrophobic, π-stacking group 
can act as efficient hydrogelators. Suitable functional groups 
include naphthalene, substituted naphthalenes, Fmoc and 
pyrene, Figure 5. 65 
 
4.1.1. Fmoc-Dipeptides 
The first examples of such gelators were dipeptides conjugated to 
Fmoc groups, a common protecting group used during peptide 
synthesis. Vegners et al.137 first demonstrated that hydrogels 70 
could be prepared using Fmoc-Leu-Asp, Fmoc-Ala-Asp or Fmoc-
Ile-Asp by the cooling of an aqueous solution at 0.5 wt% (the 
more hydrophilic Fmoc-Ala-Asp formed gels at a concentration 
of 6.7 wt%). Later, Zhang et al.134 found that a number of Fmoc-
dipeptides could form hydrogels when the solution of a Fmoc-75 
dipeptide at high pH was lowered to approximately pH 3. A 
number of dipeptides were examined including Fmoc-AlaAla, 
Fmoc-GlyGly, Fmoc-GlyAla, Fmoc-GlySer and Fmoc-GlyThr, 
with the more hydrophilic dipeptides again requiring significantly 
higher concentrations to form hydrogels (e.g. Fmoc-AlaAla 80 
formed gels at a concentration of 3.9 mM, whereas the more 
hydrophilic Fmoc-GlySer formed gels at 52 mM). These 
hydrogels were also found to be temperature sensitive. 
Interestingly, exposing Fmoc-D-Ala-D-Ala to vancomycin (known 
to have a strong ligand-receptor interaction with D-Ala-D-Ala), 85 
resulted in a gel-to-sol transition. On the other hand, vancomycin 
had no effect on the gel formed by Fmoc-L-Ala-L-Ala, 
emphasising the importance of the exact position of the amino 
acid functional groups. A number of reports regarding the use of 
Fmoc-dipeptides as hydrogelators have now appeared.71, 82, 138-143 90 
It is now known that a wide variety of Fmoc-dipeptides can form 
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hydrogels under the appropriate conditions. Perhaps the most 
widely studied of these is Fmoc-diphenylalanine (Fmoc-PhePhe), 
which was first reported as an efficient gelator in 2006.82, 138 The 
interest in this gelator arises from the fact that hydrogels can be 
prepared at physiological pH, vital for biomedical applications.  5 
Assembly of Fmoc-PhePhe has been carried out in different 
ways. The dipeptide can be dissolved in a solvent such as 
dimethylsulfoxide (DMSO) or hexafluoroisopropanol (HFIP) at 
relatively high concentrations (100 mg/mL).82, 139, 140 Dilution of 
such a stock solution with water or buffer results in the formation 10 
of a network of fibres leading to transparent hydrogels at typical 
concentrations of 5 mg/mL (0.5 wt%). Noticeably, one report 
indicates a lower stability in buffer as compared to deionised 
water, in addition to the impact of concentration of the peptide 
solution on gel stability.139 Dilution of a 100 mg/mL solution to 15 
0.5 wt% resulted in an unstable gel whereas dilution of a 25 
mg/mL solution to the same final concentration resulted in a 
stable gel.  The rheology of a hydrogel formed from Fmoc-
PhePhe in water exhibits G′ > G″ as expected for a hydrogel, with 
G′ being of the order of 104 Pa.82 As expected, the gel strength 20 
was affected by the peptide concentration. IR spectroscopy of the 
gel showed peaks at 1607, 1658 and 1691 cm-1, consistent with 
the presence of β-sheets and β-turns.82 Subsequent results from 
the same authors showed a major peak at 1653 cm-1 and a minor 
peak at 1690 cm-1 again assigned to a β-sheet conformation.140 25 
An alternative method of assembly has been reported by Ulijn et 
al.138 Here, solutions of the dipeptide above pH 8 were prepared. 
Addition of concentrated HCl to re-adjust the pH resulted in the 
formation of a self-supporting gel at pH < 8. Clearly, care must 
be taken with this method, since the Fmoc group is sensitive at 30 
basic conditions.144 Here again, a fibrous network was observed 
by SEM which led to the formation of a hydrogel. Rheology 
showed that such gels had a G′ which varied from 1900 Pa,143 to 
10,000 Pa142 to 21,000 Pa141 depending on the report. IR 
spectroscopy of these gels revealed a strong peak at 35 
approximately 1630 cm-1 and a medium intensity peak at 1690 
cm-1, indicative of the formation of anti-parallel β-sheets.141 The 
formation of β-sheets was also shown by circular dichroism,142 
where a minimum at 218 nm was observed. In this work, the 
assembly of primary fibres into tapes was observed, and a model 40 
structure generated from the data suggested that Fmoc-PhePhe 
assembles into cylindrical structures due to the formation of anti-
parallel β-sheets and anti-parallel π-stacked fluorenyl groups, 
Figure 6. 
Interestingly, later work showed that the reason for assembly 45 
at physiological pH was the surprisingly high apparent pKa of the 
C-terminus of the dipeptide.145 Titration with HCl revealed this 
value to be approximately 9.9 with a second apparent pKa found 
at approximately 5.8. These apparent pKa values were related to 
two different structural transitions resulting from the self-50 
assembly process. Titrating to different pH values resulted in 
significantly different IR spectra to that found on gelation at pH 
7, with two strong peaks at 1625 and 1687 cm-1 found at both pH  
9.1 and 6.8. Whilst the positions are still reminiscent of the 
formation of anti-parallel β-sheets, the intensity of the peak at 55 
1687 cm-1 was surprisingly strong and differed from that reported 
previously.141 Similarly, the rheology for a slowly titrated system 
shows significantly lower values of G′ (1 Pa compared to 104 Pa). 
It is known for a number of different systems that the kinetics of 
hydrogelation strongly affects the outcome of the process.35, 71, 146, 60 
147 In all cases, lowering the pH past the second apparent pKa 
results in precipitation, with TEM showing large flat ribbons at 
lower pH where a gel is no longer present. IR spectroscopy 
demonstrates that the β-sheets were broken up with evidence of 
random coils appearing at low pH. 65 
 
 
Figure 6. A model structure of Fmoc-PhePhe peptides in an anti-
parallel β-sheet arrangement. (a) π-stacking occurs between Fmoc 
groups from alternate β-sheets. (b) To maintain the interactions 70 
between the fluorenyl groups and allow the twist of the β-sheets, 
a cylindrical structure is formed. Adapted from Smith et al.142 
Reproduced by permission from Wiley-VCH. 
 
To date, these Fmoc-PhePhe hydrogels have been utilised in two 75 
applications, encapsulation and cell culturing. The gels could be 
used to control the release of drugs; fluorescein was shown to 
diffuse through the gels with a diffusion coefficient of 3.61 x 10-
10 m2 s-1, whereas the larger fluorescein-labelled insulin was 
retained in the gel.82 Recent results have shown that the mesh size 80 
decreases with dipeptide concentration in these gels, with the free 
space between the fibrils being of the order of 12 nm at a 
concentration of 4 mg/mL.83 Additionally, Chinese hamster ovary 
cells were found to be viable when suspended about the gel.82, 140 
Liebmann et al.139 demonstrated that the addition of a peptide 85 
solution in DMSO to a cell-containing PBS buffer solution 
resulted in the formation of a gel containing the cells. Diffusion 
of dyes within the gels was again demonstrated, Figure 7. Cell 
growth within hydrogels prepared from Fmoc-PhePhe as well as 
those prepared from mixtures of Fmoc-PhePhe and Fmoc-amino 90 
acids has also been demonstrated by Ulijn‟s group.138, 141, 143 
As noted above, a range of other Fmoc-dipeptides are also 
efficient hydrogelators. When assembled by a pH trigger, these 
require a lower pH than Fmoc-PhePhe. However, it has been 
shown that Fmoc-PheGly still forms a hydrogel when a solution 95 
in DMSO is diluted with ultrapure water.140 Recently, it has been 
shown that the hydrolysis of glucono-δ-lactone (GdL) to gluconic 
acid can be used to induce a pH change in Fmoc-dipeptide 
solutions.71 This has two main advantages. Firstly, the rate of 
GdL dissolution is far higher than the rate of hydrolysis, meaning 100 
that a highly uniform and reproducible gel can be prepared using 
this technique since mixing is not required during the actual 
gelation. Secondly, the rate of hydrolysis is sufficiently slow that 
the process by which assembly occurs can be followed. Using 
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this technique, it was demonstrated that the fluorescence 
spectrum changes immediately, showing the red shift often 
reported on assembly of Fmoc-dipeptides, implying that π-
stacking is occurring as the first step of the assembly process. The 
circular dichroism spectra on the other hand showed that the 5 
formation of structures giving rise to these signals takes 
significantly longer. Using microscopy, it was shown that 
assembly into fibres begins as soon as the pH starts to drop, with 
long fibres being formed well in advance of any gel-like 
properties being measureable by rheology in agreement with the 10 
spectroscopic data. Using this method, very stiff gels with a G′ of 
up to 184,000 Pa could be reproducibly prepared at 
concentrations of 3 mg/mL. Recent results show that, at a 
concentration of 14.6 mM, the hydrophobicity of the Fmoc-
dipeptides determines whether a gel will form at pH 4.148 Fmoc-15 
dipeptides with a logP (a measure of the hydrophobicity) lower 
than 2.4 form gels that synerise, those with a logP between 2.4 
and 5.5 form stable gels and Fmoc-PhePhe (logP = 5.6) does not 
form a gel at this pH, in agreement with other results.145 
 20 
 
Figure 7. Dye diffusion through a Fmoc-PhePhe hydrogel 
achieved by applying a green stain to the bottom a moulded gel. 
The height of the sample is approximately 20 mm.139 
 25 
A number of recent reports from the Ulijn group have 
demonstrated that gelation can also be induced and controlled by 
enzymatic-triggered assembly. Enzymatic-triggered assembly has 
also been demonstrated for Fmoc-amino acids.149-151 In the first 
example,152 thermolysin was used to couple a dipeptide to a 30 
Fmoc-amino acid. Fmoc-tripeptides were formed in varying 
yields, with gels being formed on yields of as little as 16 wt% 
tripeptide (corresponding to approximately 4 mg/mL). Gelation 
was tested by vial inversion. Further work extended this to Fmoc-
dipeptide methyl esters, which were able to form a hydrogel 35 
when threonine was used as the first amino acid in the 
sequence.153 It was also demonstrated that Subtilisin, an enzyme 
used for ester hydrolysis, could be used to convert a sol of an 
Fmoc-dipeptide methyl ester to an Fmoc-dipeptide at 55 °C. On 
cooling, hydrogels were formed. High yields of de-esterification 40 
were achieved. It was later demonstrated that enzyme-triggered 
assembly allows localised nucleation and growth with fibres 
being aggregated around the enzyme at early time points (Figure 
8).154 The complexity of the thermolysin system has been 
described, showing that the outcome of the process depends on 45 
the composition of precursors in the system, with a dynamic 
combinatorial approach being taken.155 
 
Figure 8. TEM image demonstrating spatial confinement of 
nucleation and growth. Fibres are observed locally to an enzyme 50 
at early time points in the enzyme-assisted assembly of Fmoc-
PhePhePhe. Scale bar = 100 nm. Reprinted by permission from 
Macmillan Publishers Ltd: Nature Nanotechnology, Williams et 
al.154 copyright 2009. 
 55 
Gels can be formed from conjugates with longer peptides 
attached to a Fmoc unit.156 The use of Fmoc-tripeptide gelators 
has recently been demonstrated which formed gels at low pH as 
for the dipeptides and also at high pH in a borax buffer.157 Ma et 
al. have used Fmoc-pentapeptides to form hydrogels. Again, a pH 60 
trigger was used to form the gels, with the pH at which the gels 
formed being dependant on the peptide sequence.158 Longer 
peptides can also be used. A Fmoc group was conjugated to a 
fragment of the transthyretin protein (TTR105–115). This fragment 
is known to form fibrillar structures akin to amyloid fibres. 65 
Cooling a solution of the peptide conjugate slowly from 70 oC to 
40 oC resulted in the formation of a gel. Whilst the gel properties 
were not studied, it is interesting to note that in this case, 
extended π-stacking was not thought to be present. On the other 
hand, recent results from Xu et al. demonstrate that efficient 70 




Whilst significant work has been done regarding Fmoc-75 
dipeptides, these are by no means the only examples of N-
functionalised dipeptide gelators. A pyrene-dipeptide has been 
reported.135 Whilst the gels formed using D-Ala-D-Ala as the 
dipeptide were relatively weak (G′ = 120 Pa), binding to 
vancomycin (as described above for Fmoc-D-Ala-D-Ala) resulted 80 
in a large increase in the gel stiffness (G′ = 160,000 Pa). 
Moreover, the use of the L-Ala-L-Ala dipeptide resulted in a 
comparatively low ten-fold increase in G′ over the gelator alone. 
 
4.1.3. Naphthalene-Dipeptides 85 
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A significant amount of work has also been carried out with 
naphthalene-dipeptides. As with the Fmoc-dipeptides and pyrene-
dipeptides, the naphthalene rings are thought to provide π-
stacking interactions that help induce one-dimensional assembly 
and hence fibre formation. Xu‟s group have reported a number of 5 
hydrogels utilising naphthalene-dipeptides. Hydrogels were 
successfully prepared from a subset of a library of naphthalene-
dipeptides.136 Those that formed gels did so at a peptide 
conjugate concentration of around 1mg/mL at approximately pH 
4. As for their other hydrogels prepared from low molecular 10 
weight gelators, the gels were found to exhibit a gel-to-sol 
transition at increased temperature (45 – 52 °C in these cases). 
Interestingly, the naphthalene-dipeptides that successfully formed 
gels had an OCH2 linker between peptide and naphthalene ring 
(see Figure 5c). Conversely, a CH2 linker resulted in 15 
precipitation. This was attributed to the OCH2 spacer allowing the 
necessary conformations to be adopted, with a simple model 
demonstrating that this linker allowed planarity to be achieved. 
As for gels prepared from Fmoc-dipeptides,71 a weak frequency 
dependence was observed by rheology with G′ > G″ as expected 20 
for a hydrogel. In these cases, helical fibres were formed, with the 
helicity being opposite when L- or D- peptides were used, 
respectively. As for the Fmoc-dipeptides discussed above, these 
hydrogels were found to be biocompatible as confirmed by an 
MTT assay using HeLa cells. 25 
Further work has focused on the use of naphthalene-dipeptides 
where β-amino acids were coupled to a naphthalene ring.159 
Oligopeptides that are formed from the naturally occurring L-
amino acids are known to be biodegradable by proteolysis, which 
can result in a shortening of the in vivo lifetimes.160, 161 Hence, the 30 
β-amino acids are used to confer proteolytic resistance to 
hydrogels. As for the gelators prepared from D- or L-amino acids, 
the naphthalene-β-Phe-β-Phe dipeptide formed gels at 
concentrations of 5 mg/mL and pH 6.2. Interestingly, the less 
hydrophobic naphthalene-Gly-Ala formed gels at pH 4.3, 35 
possibly due to a change in pKa of the terminal carboxylic acid as 
described above for the Fmoc-dipeptide series. Also, these 
dipeptides were not linked to the naphthalene ring by an OCH2 
spacer, which was mooted above as being important. A gel-to-sol 
transition at 45 – 48 °C (depending on the sequence) was 40 
observed. The gels formed from these dipeptides had G′ of 100 – 
200 Pa, significantly lower than found for other naphthalene-
dipeptides and Fmoc-dipeptides (see above). 
Further work with the naphthalene-β-Phe-β-Phe hydrogels 
used radioactive tracers to examine the controlled release from 45 
these systems.162 An MTT assay with HeLa cells was used to 
assess biocompatibility and the gels were found to have an IC50 
(the half maximal inhibitory concentration i.e. the concentration 
needed to inhibit cell growth by 50%) higher than 500 µM. Also, 
as expected from the use of β-amino acids, the gels were found to 50 
resist enzymatic degradation with proteinase K (for comparison, 
gelators prepared using L-amino acids degraded quickly, with 
only 37 % remaining after 24 h). Additionally, no clinical, 
haematological or biochemical toxicity was observed when 
subcutaneous injection of the gels was carried out under the 55 
middorsal skin of rats with no obvious inflammation observed 
after 42 days. Controlled release was imaged via single photon 
emission computed tomography and showed that the release of 
epideride from the gel occurred over a few hours and was slower 
than when simply injecting drug solution. 60 
 
Figure 9. (a) Normalised change in ThT fluorescence at 485 nm 
(λex = 455 nm) on addition of solutions of dipeptide derivative to 
GdL (blue data). Overlaid is the change in pH with time (red 
data). (b) X-ray fibre diffraction patterns collected from in situ 65 
prepared fiber alignments from gel at a final pH of 5.0. The fibre 
axis is vertical to the diffraction pattern. The major meridional 
reflection was found to be at 4.5 Å, arising from the β-strand 
spacing along the fibre axis.  Reprinted with permission from 
Chen et al.163 Copyright 2010 American Chemical Society. 70 
 
Recently, the assembly of a brominated naphthalene-dipeptide to 
form a hydrogel was studied in detail.163 Utilising GdL to alter 
the pH allowed the rate of assembly to be controlled. Assembly 
was shown to start as the pKa of the dipeptide was reached. As for 75 
Fmoc-PhePhe discussed above, the apparent pKa was found to be 
higher than expected for the C-terminus of a peptide 
(approximately 5.4). As the pH was decreased, the formation of 
β-sheets was demonstrated by IR and X-ray fibre diffraction, 
Figure 9. The rate of assembly was shown to have an effect on 80 
the ability of the gels to withstand strain, although the absolute 
values of G′ were found to be independent of the rate of 
assembly. Assembly was also shown to proceed via a two-stage 
process by the incorporation of thioflavin T (ThT, a stain 
typically used for amyloid proteins).  85 
In addition to pH-triggered gelation, hydrogels have been 
prepared from naphthalene-β-Phe-β-Phe-α-Tyrphosphatase using 
an enzyme to cleave the phosphate from the terminal amino 
acid.146 The tripeptide forms gels at 0.5 wt% and a pH of 1.5, but 
above this pH, no gel is formed. However, using an acid 90 
phosphatase to cleave the phosphate causes gel formation at pH 
4.8. Gels were also found to form in the presence of blood. The 
kinetics of gelation depended on the concentration of the enzyme 
used, which was found to link directly to the mechanical 
properties of the gels. G′ for the gels was found to be higher the 95 
quicker the gel was formed (i.e. the higher the amount of enzyme 
used, the higher the storage modulus, reaching a maximum G′ of 
4000 Pa). In addition, the fibre uniformity decreased as the rate of 
gelation increased. This clearly shows that the speed of gelation 
affects both the morphology of the nanofibres and the mechanical 100 
properties of the final gel. This presumably correlates with the 
observations regarding sample uniformity and G′ values in the 
discussion regarding the Fmoc-dipeptides above. 
4.2. Peptide-amphiphiles 
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Although there are many examples of amphiphilic peptide-
based molecules, the term “peptide-amphiphile” (PA) is 
generally used for molecules with a hydrophilic peptidic 
segment covalently attached to a linear alkyl chain (see Figure 
10). Conventionally, the alkyl chain is attached to the N-5 
terminus of the peptidic moiety leaving a free terminal 
carboxylic acid on the peptide. Reverse PAs, on the other 
hand, have a free terminal amine group as the hydrocarbon 
chain is attached to the C-terminus. Other systems, which are 
not covered in this review, include amphiphilic amino acid 10 
sequences (where the hydrophobic and hydrophilic character 
is provided by the residues themselves) and block 
copolypeptides. For a tutorial review covering these different 
peptidic amphiphiles, the reader is directed elsewhere.164 
PAs benefit from the self-assembly behaviour of 15 
conventional amphiphiles (in aqueous media the hydrophobic 
segments bury themselves to reduce their unfavourable 
interactions with the surrounding hydrophilic environment165) 
to form cylindrical micellar nanofibres. These materials will 
form viscoelastic three-dimensional hydrogels when the 20 
concentration is sufficiently high to cause intermolecular 
entanglement of the fibres. More importantly, however, unlike 
with conventional block copolymer amphiphiles, the 
incorporation of the peptide sequence allows considerable 
control over the self-assembly process and the final physical, 25 
chemical and biological properties of the hydrogels. The 
biocompatible peptide segment has an adaptable composition 
(chain length, charge and sequence), which can be drastically 
altered or finely-tuned to suit the target application. 
 PA hydrogels were first designed to direct mineralisation of 30 
calcium hydroxyapatite (the inorganic constituent of 
assemblies in bones and teeth).23 The specific self-assembling 
behaviour of the PA provided the perfect scaffold for 
crystallisation of the mineral, as crystal growth was directed 
along the axes of the nanofibres. Moreover, the morphology 35 
of the final material somewhat mimicked that observed 
between collagen and calcium hydroxyapatite in bones. In this 
first example, however, the PA had a more complicated 
primary structure than many of its successors. The peptidic 
segment of the molecule consisted of four major parts; i) a 40 
reversibly crosslinkable peptide segment comprising of 
cysteine residues, ii) a flexible triglycine linker, iii) an apatite 
crystallisation-directing group (phosphorylated serine) and iv) 
the commonly used bioactive epitope, RGD. More recently, 
Paramonov et al.123 carried out a systematic study on 26 PAs 45 
to identify to essential design rules for effective self-assembly 
into bioactive nanofibrous hydrogels. The authors found that 
there were only three vital segments of the PA required; i) a 
hydrophobic aliphatic tail (the precise length needed depends 
on the peptidic head group125), ii) a critical four amino acid 50 
sequence with -sheet forming propensity to direct hydrogen 
bonding along the axis of the nanofibres and iii) a peripheral 
peptide region for bioactivity. Control of the -sheet forming 
section was shown to have the most influence on the final 
morphology, with the absence of -sheet formers giving rise 55 
to spherical nanostructures in place of nanofibres with high 
persistence lengths. The amino acid residues on the periphery 
of the PA were shown to have little effect on the morphology; 
this segment can therefore be used to insert some kind of 
“code” of (bio)activity depending on the target application 60 
required. Obviously, other units can be incorporated into the 
structure for varying applications, but these constitute the 
ground rules for all PA nanofibre design parameters. 
Figure 10. (A) Chemical structure of the peptide amphiphile, 
highlighting five key structural features. Region 1 is a long alkyl 65 
tail that conveys hydrophobic character. Regions 2-5 are different 
peptidic domains important for cross-linking, flexibility, 
interaction with calcium and cell adhesion, respectively. (B) 
Molecular model of the PA showing the overall conical shape of 
the molecule going from the narrow hydrophobic tail to the 70 
bulkier peptide region. (C) Self-assembly of PA molecules leads 
to a cylindrical micelle. From Hartergink et al.23 Reprinted with 
permission from AAAS. 
 
Since this pioneering work, PA gels have been used as in vivo 75 
angiogenic (growth of new blood vessels from existing ones) 
materials,166 hybrid bone implants,96 scaffolds for cell 
adhesion,167 dental stem cells168 and rat neurons169 and for the 
differentiation of human bone marrow cells.170 One of the 
major advantages of PAs is their versatility in molecular 80 
design. For example, a variety of functional groups can be 
incorporated into the construct to produce materials which 
only gel in the presence of a specific trigger. This is 
particularly useful in the field of biomedicine, where changes 
in physiological conditions or external stimuli can be used to 85 
create biomimetic scaffolds in vivo. Such triggers include 
light,171, 172 heparin,173 calcium,174 cis-platin175 and counter 
ion screening.176  
 In contrast to the Fmoc-peptide derivatives discussed in 
section 4.1, PAs have not been used extensively to create 90 
particularly strong gels (G′ typically around 200 Pa or 
lower,127 although there are exceptions77) and have generally 
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been used as biomedical scaffolds. Some work has been 
undertaken, however, to optimise the strength of PA 
hydrogels. For example, different aliquots of phospholipids 
were added to PA samples prior to self-assembly.177 The 
phospholipids were shown to substitute for PA molecules in 5 
the nanofibres to create hydrogels of varying strengths 
depending on the amount of phospholipid added (in this case, 
5 mol % was revealed as optimum for mechanical strength). 
This carefully controlled study showed, for the first time, that 
additives can be used to strengthen PA hydrogels at  no 10 
detriment to structural conformation. More recently, Anderson 
et al.127 showed that a biologically inert PA could be 
effectively mixed with a bioactive PA to enhance structural 
stability of the final hydrogel whilst maintaining the 
material‟s biological function. In some cases, the cell-binding 15 
PAs were not able to form standing hydrogels without the 
incorporation of the structural PA additive, demonstrating the 
value of this approach for cell encapsulation and other tissue 
engineering applications. A similar strategy was also 
exemplified by Niece et al.122 who combined two oppositely 20 
charged PAs and studied their self-assembly behaviour. On 
their own, the PAs did not form hydrogels due to the 
electrostatic repulsion between peptidic segments. However, 
once mixed at concentrations as low as 0.1 mg/mL, the PAs 
formed gels comprising composite nanofibres. Reverse PAs, 25 
where the aliphatic tail is bound to the C-terminus of the 
peptide, can also be used in this way.99, 178 Mixtures of reverse 
PAs and conventional PAs were shown to create more 
thermally stable hydrogels. This was attributed to a more 
efficient alignment of the -sheets due to anti-parallel 30 
stacking of the combined PAs.99 Gels made from just one type 
of PA can only align in a parallel fashion and so the inter-
peptide bonding is not as intimate. PA molecules have also 
been chemically cross-linked to improve their toughness using 
pairs of acetylene groups within the hydrocarbon tail.179 The 35 
acetylene groups align perfectly due to the specific self-
assembling of the peptidic segment. Once nanofibres are 
formed (by physical interactions only), light irradiation can be 
used to permanently hold the structure together, Figure 11. 
This approach exploits the specificity of -sheet formation of 40 
peptides to produce chemically stable nanofibres. 
 Greenfield et al.77 showed that the mechanical properties of 
the hydrogels can be controlled by altering the aqueous media 
in which they are placed rather than altering the composition 
of the PA or incorporating additives. Gelation, stiffness and 45 
strain response were found to be different if either HCl or 
CaCl2 was used to induce gelation. CaCl2-PA hydrogels were 
shown to be stronger (due to ionic bridging as compared to 
hydrogen bonding in HCl), however HCl-PA gels recovered 
most of their stiffness following deformation. This elegant 50 
approach shows that the PA does not necessarily have to be 
modified to control the mechanical behaviour of the hydrogel; 
however, the in vivo application of this strategy will be 
heavily dependent on the physiological conditions in which 
the material is placed.  55 
 Controlling the kinetics of the gelation process is also vital 
for in vivo applications of PA hydrogels. This can be done by 
molecular design; subtly altering the amino acid sequence in 
the peptide has huge implications on the rates of self-
assembly. A number of PAs have been investigated in this 60 
way.124 The results suggest fibre formation is nucleated by 
aggregates that pre-exist the onset of the trigger for gelation. 
Hence, the more hydrophobic PAs accelerate gelation 
compared to the more hydrophilic PAs due to a higher 
concentration of these nuclei. The rate of gelation could be 65 
tuned by altering the bulkiness of the amino acids used and 
the hydrophobicity of the overall peptide sequence. 
Figure 11. (a) Molecular structure of two PA molecules 
incorporating a photocrosslinkable diacetylene segment 
(circled). (b) Illustration of the polymerisation reaction of the 70 
diacetylene segments when UV irradiated. Figure taken from 
Mata et al.179 Reproduced by permission of The Royal Society 
of Chemistry. 
 
PAs have been proven to be effective scaffolds for crystal 75 
nucleation and consequent directed growth. Additionally, 
Stupp‟s group have shown that lithographical techniques can 
be employed to control the structure of the PA nanofibrous 
networks.179, 180 By combining lithography with structure-
directing PAs, one can begin to control the nanoparticle 80 
morphology of a wide variety of materials, including metals 
like gold.181 This latter example, controlling the growth of 
gold nanoparticles, actually uses a subtly different class of PA 
as the structure-directing scaffold. The PA consists of only 
two major components; the aliphatic tail and a positively 85 
charged amino acid or dipeptide head group. These materials, 
pioneered by Das, have potential as vectors for antimicrobial 
activity due to the ability of cationic ammonium amphiphiles 
to penetrate cell membranes.112, 182, 183 
 Peptide chains can also be “grown” orthogonally to the 90 
original peptidic segment of a PA to yield branched PAs. 
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These self-assemble in the same manner as conventional PAs 
to afford nanofibres (which consequently entangle to produce 
hydrogels), but additionally allow the multiaddition of 
functional groups, such as MRI agents98, 184 (to non-invasively 
image scaffolds as a means of in vivo fate mapping, tracking 5 
how the PAs will behave under different physiological 
conditions), bioactive epitopes97, 185 and catalytic groups.186 
The major advantage of branched PAs over conventional PAs 
is that they offer a higher density of binding sites for 
biological activity. Additionally, the extensive work carried 10 
out by Stupp suggests that they also provide further control 
over the self-assembly process. 
 There is increasing interest in peptide-amphiphiles, due to 
their biocompatibility, specific self-assembling behaviour and 
highly controllable molecular composition.187 As progress 15 
continues in this field, the biomedical applications of such 
hydrogels become more diverse. 
 
4.3. Polymer-peptide conjugates 
Although the range of applications of PAs is broad, there is an 20 
upper limit due to the simplicity of the hydrocarbon tail; in 
that its sole function is to drive self-assembly. Modifying a 
peptide with a polymer, however, means that one can 
introduce a whole host of features into the biomaterial. The 
resulting polymer-peptide conjugate boasts versatility in both 25 
bioactivity (from control over the specific amino acid 
sequence in the peptidic moiety) and physical properties (from 
control of the polymer functionality, architecture, 
biocompatibilty, protein-adsorption resistivity and molecular 
weight). Such properties inferred from polymer incorporation 30 
can include prolonged in vivo lifetimes, stimuli-responsive 
behaviour and increased thermal stability. Additionally, it is 
well documented that the viscoelasticity of the extracellular 
matrix (or synthetic hydrogel substitute) affects cell 
behaviour,188-192 therefore it is vital we can control the 35 
mechanical stiffness of biomaterials intended for cellular 
uptake. There are a plethora of examples whereby polymer-
peptide conjugates self-aggregate into fibrillar ( -sheet) or 
helical substructures and it is very probable that such 
materials would form “bioinspired” hydrogels under the 40 
appropriate conditions.46, 94, 101-103, 110, 193-197 However, these 
reports, and many more, do not mention the study of the 
hydrogel formation of their material and are therefore beyond 
the scope of this review and the reader is directed elsewhere.2 
This area is calling out for further work, with the library of 45 
materials being available; they just have not yet been tested 
for this purpose. In this section we review work which 
specifically discusses polymer-peptide conjugates as 
hydrogelators only. 
 Chung et al.198 have created a polymer-peptide hydrogel to 50 
enhance bone formation, as exempfiled in mice. GRGDS, the 
common cell binding motif, was integrated into a 
thermoresponsive organophosphazene repeat unit. The final 
polymer-peptide conjugate had the thermal sensitivity of the 
synthetic polymer; being an injectable fluid at room 55 
temperature and a viscoelastic scaffold at body temperature, 
and the bioactivity of the GRGDS sequence. Consequently, 
the fluid was injected into a mouse, where it spontaneously 
self-assembled to create a bioactive gel that was used as a 
stem cell scaffold to induce osteogenic differentiation. Such 60 
injectable, yet biodegradable, material promises for future 
application in human cell delivery, as discussed in detail in a 
recent review by Chung and Park.199 
 Mei et al.105 attached the same bioactive epitope, GRGDS, 
to a poly(hydroxyethyl methacrylate), PHEMA, chain and 65 
tested the cell activity within the hydrogel structure. The 
incorporation of a small amount of peptide (approximate 
polymer:peptide weight ratio of 6:1) caused the hydrogel to 
induce cell adhesion and spreading. It is noteworthy that the 
authors did not report any optimisation of this level of peptide 70 
integration and could indeed function at even lower amounts. 
Such low peptide loadings suggest that the mechanical 
properties of conjugates would not be drastically altered when 
incorporating bioactivity. Moreover, the synthetic strategy 
employed by the group (growing the polymer from the peptide 75 
by ATRP) extends the scope of available polymers and 
molecular weights. This provides even more control over the 
hydrogel properties. It is somewhat suprising therefore that 
this approach has not been used to produce a wide range of 
polymer-peptide constructs for controlled hydrogel synthesis. 80 
Using a convergent approach to construct PEO-tetrapeptide 
conjugates, Tzokova et al.50, 51 investigated the PEO 
incorporation to look at the self-assembly of the 
tetraphenylalanine and tetravaline-containing compounds in 
water. Hydrogels were formed (from nanotubes with -sheets) 85 
using phenylalanine with sufficiently low levels of PEO 
content (namely PEO7-PhePhePhePhe). Higher PEO loadings 
caused the conjugates to adopt a variety of structures, such as 
wormlike micelles, more similar to those formed by 
conventional amphiphilic block copolymers.50 Conversely, 90 
conjugates containing valine did not form hydrogels at all 
concentrations tested. Instead they produced plaque-like 
aggregates due to the stronger -sheet forming propensity of 
valine. Kopecek‟s group52, 109, 120 have exploited the formation 
of -helices to physically crosslink stimuli-responsive 95 
polymers. The peptidic physical crosslinks provided structural 
integrity to afford controllable and reversible hydrogels, as 
shown in Figure 12. N-(2-Hydroxypropyl)methacrylamide 
(HPMA) was copolymerised with a methacrylamide peptide 
macromonomer109 or a functionalised monomer capable of 100 
accommodating a peptide graft52, 120 to produce comb-like 
conjugates. The authors illustrated the importance of the 
make-up of the peptidic component for producing hydrogels. 
Peptides, based on helical-forming heptads, were found to 
induce hydrogelation when comprised of four heptad repeats 105 
or more. Furthermore, coiled-coils were observed when the 
peptide grafts consisted of a minimum of five heptads. 
Hydrogels were formed at low concentrations (> 5.54 mg/mL) 
of the same material, but could also be produced at much 
lower concentrations (> 1 mg/mL), when using equimolar 110 
mixtures of oppositely charged peptide combs. Moreover, the 
use of HPMA inferred a number of advantages to the 
bioinspired hydrogels. For example, the materials were shown 
to exhibit thermoresponsive behaviour in addition to having 
higher thermal stabilities. This work highlights the degree of 115 
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control associated with polymer-peptide conjugates. The level 
of peptide incorporation and type of peptide sequence can also 
control the mechanical properties of the material in addition to 
control over the stimuli-response and other physicochemical 
properties with the polymer moiety. 5 
Figure 12. Schematic of the hydrogelation process through 
anitparallel coiled-coil aggregation, illustrating one of the 
many possible conformations of such helical physical 
crosslinks. Adapted with permission from Yang et al.120  
Copyright 2006 American Chemical Society. 10 
 
The incorporation of a polymer into a peptide has been shown 
to be extremely effective in changing the chemical and 
physical properties of peptide epitopes by using polymers of 
specific types. Another important feature of a polymer-peptide 15 
conjugate is its final architecture i.e. the manner in which the 
polymer is attached. For example, Ganesh et al.200 synthesised 
two conjugates comprising oligo(ethylene oxide) and 
triisoleucine; one as a diblock “copolymer” and one as a 
triblock with the peptide segment bridging two oligo(ethylene 20 
oxide) segments. The diblock entity was shown to form rigid 
rods (with antiparallel stacking), whereas the triblock was 
shown to create a non-covalently bound mesh of parallel -
sheets. Both materials were shown to form gels, yet the 
diblock showed increased solubility in alcohols compared to 25 
the triblock and is expected to have much lower mechanical 
strength (due to the lack of crosslinking). This is a very 
interesting example of how subtleties in primary chain 
architecture can drastically affect the final hydrogel 
properties. In a similar example, Jing et al.53 showed that 30 
although their PEO-peptide diblock copolymer was a viscous 
liquid, the peptide-PEO-peptide triblock counterpart formed 
viscoelastic hydrogels due to the association of the peptide 
endgroups into coiled-coils. This work clearly demonstrates 
that when designing biomaterials one must not only carefully 35 
select the peptide and polymer, but must also construct the 
conjugate appropriately. 
 Modified peptides, which also fit into the scope of this 
review, but are not strictly polymer-peptide conjugates have 
been studied by Kelly and coworkers.201 Briefly, the authors 40 
attached two peptide blocks to a dibenzofuran linker, which 
preorganised the peptidic molecules into dimers. The dimers 
further self-assembled into -sheets, which formed fibrils with 
a hydrophobic edge to drive filament assembly. This work, 
published in 2000, was instrumental to a vast proportion of 45 
the work discussed in this review. They discuss the concepts 
underpinning -sheet fibril formation, which is vitally 
important for controlling the assembly process, particularly 
for in vivo applications. 
 It is worth noting that polymer incorporation has also been 50 
used to inhibit the gelation of peptides.93, 202-205 Diblocks and 
triblocks containing PEO blocks flanking peptide segments 
have been synthesised in order to prevent lateral fibril-fibril 
aggregation into macromolecular assemblies. The peptidic 
domains on individual fibrils cannot approach each other due 55 
to the tethered polymer chains. This work is particularly 
useful in controlling amyloid fibre formation, an irreversible 
process well known to be the major contributor to 
Alzheimer‟s disease. Controlling the reversible formation of 
such plaques, for example, is seen to be a step towards 60 
combating such devastating maladies in the near future. 
5. Conclusions and Future Outlook 
Many peptide-conjugates can be used to prepare hydrogels. 
Whilst falling into three main classes, it is clear that the 
structural diversity is extremely large, with an array of 65 
different molecules capable of forming a gel on assembly. In 
many ways, this structural diversity is one of the greatest 
challenges to the field. Whilst all the examples cited above 
clearly demonstrate highly successful means of preparing 
hydrogels, it is difficult to those outside the field to appreciate 70 
the differences between the systems. Indeed, in many cases, 
the mechanical properties of the hydrogels formed are not 
reported, which makes comparing the final gels prepared 
extremely difficult. Hence, whilst many of these hydrogelators 
have been used to prepare gels for cell scaffolds for example, 75 
a direct comparison is in many cases impossible. On top of 
this, the design of hydrogelators is also difficult. It is often 
unclear why one peptide-conjugate will successfully form 
hydrogels whilst a structurally similar analogue will not. For 
example, Fmoc-PheGly is a well-known hydrogelator,140 80 
whilst Fmoc-GlyPhe (where the order of the amino acids has 
been swapped) does not form gels.138, 140 Hence, designing a 
successful hydrogelator from first principles is often difficult. 
Further complications arise from recent observations that the 
method of assembly can lead to gels with different properties. 85 
In many of these cases, it is likely that the method of 
assembly is an often-overlooked, but crucial parameter that 
requires further investigation. Nevertheless, these classes of 
peptide-conjugates can be used to prepare hydrogels with a 
range of properties and, with the current interest in these 90 
molecules and the hydrogels themselves, we anticipate that 
great strides in understanding will occur in the near future. 
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